AGMB News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-10 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |
| 2026-08-06 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |
| 2026-06-23 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |
| 2026-05-27 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |
| 2026-04-24 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |
| 2026-03-05 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |
| 2026-02-09 | Foreign issuer report | SEC filing | Agomab Therapeutics NV filed Form 6-K | Agomab Therapeutics NV filed Form 6-K. |